Ingo Krech

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The bioengineered tissue plasminogen activator tenecteplase is an important treatment modality of acute myocardial infarction recommended by international guidelines. Following introduction of originator tenecteplase (brand names Metalyse(®) and TNKase(®)), a "biosimilar" tenecteplase became available for commercial use in India under the brand name(More)
  • 1